Sen. Ron Wyden (D-Ore.) says it’s time for Congress to shine a light on a business with extraordinary control over prescription drug prices—Pharmacy Benefit Managers (PBM). “I believe this is an industry going in the wrong direction,” Wyden said during a hearing hosted by the Senate Finance Committee on March 30. The hearing was titled…
Experts Say Transparency Needed in Drug Pricing Practices
Lack of Tranparency in Trials for Cancer Medication: Study
A multi-national study led by Australia’s Flinders University has found that more than 50 percent of the clinical trials the U.S. Food and Drugs Administration (FDA) used to approve anti-cancer medications over the past decade are not available for public scrutiny. This comes after the pharmaceutical industry made a commitment in 2014 to improve data transparency….
Facts Matter (April 22): How Big Tech (and Postal Workers) Censor Honest Covid Reporting: Speech from Global Covid Summit
The Global Covid Summit was held in Houston, Texas, about a week ago. It served as a COVID post-mortem wherein the doctors laid out what they believe specifically went wrong with the government’s management of COVID-19 over the past two years, in regards to things like the suppression of early treatment, the lack of transparency,…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`